The biotechnology company uses pioneering cell engineering to replace damaged cells in the eye to tackle age-related or inherited sight loss. The technology could potentially restore sight to millions affected.
The experts at Tenpoint Therapeutics, from the UCL Institute of Ophthalmology, Moorfields Eye Hospital, Institut de la Vision in Paris and the University of Washington in the US, are the first to combine different types of cell-based therapeutics and enable treatments that are tailored to the nature of individual cases, replacing cells in the eye that have been damaged by age-related or inherited disease.
Q&A with UCL’s Three-Minute Thesis Competition winner Agatha Alves Anet
We spoke to the winner of UCL's 2025 Three-Minute Thesis competition about her research on anxiety disorders.
24 Jun 2025
Congratulations to Professor Christiana Ruhrberg for being awarded a grant by the Leducq Foundation
The Leducq Foundation is an international grant-making organisation with a mission to improve human health through international efforts to combat cardiovascular disease and stroke.
24 Jun 2025
Congratulations to the recipients of the 2025 IoO Awards
Last week we announced the recipients of the 2025 institute awards.
23 Jun 2025